1-12 of 12
Jia Wang
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Sonrotoclax overcomes BCL2 G101V mutation–induced venetoclax resistance in preclinical models of hematologic malignancy

Jiuyang Liu, Shuran Li, Qin Wang, Yingcai Feng, Haimei Xing, Xuefei Yang, Ying Guo, Yunhang Guo, Hanzi Sun, Xiaoxin Liu, Shasha Yang, Zhu Mei, Yutong Zhu, Zhenzhen Cheng, Shuaishuai Chen, Min Xu, Wenjing Zhang, Nanyan Wan, Jia Wang, Yanwen Ma, Shuo Zhang, Xudong Luan, Aiying Xu, Lin Li, Haitao Wang, Xiaolong Yang, Yuan Hong, Hai Xue, Xi Yuan, Nan Hu, Xiaomin Song, Zhiwei Wang, Xuesong Liu, Lai Wang, Ye Liu
Journal: Blood
Blood (2024) 143 (18): 1825–1836.
https://doi.org/10.1182/blood.2023019706
Published: 2024
Includes: Supplemental data
Journal Articles

Efficacy and Safety of Fedratinib in Patients with Myelofibrosis Previously Treated with Ruxolitinib: Results from the Phase 3 Randomized FREEDOM2 Study

Claire N Harrison, Ruben Mesa, Moshe Talpaz, Haifa Kathrin Al-Ali, Blanca Xicoy, Francesco Passamonti, Francesca Palandri, Giulia Benevolo, Alessandro M. Vannucchi, Clemence Mediavilla, Alessandra Iurlo, InHo Kim, Patrick Brown, Christopher Hernandez, Shelonitda Rose, Jia Wang, Jean-Jacques Kiladjian
Journal: Blood
Blood (2023) 142 (Supplement 1): 3204.
https://doi.org/10.1182/blood-2023-173391
Published: 2023
Journal Articles

Comparison of Efficacy and Side Effects of BTK Inhibitors for Different Duration As a Bridging Therapy before Anti-CD19-CAR T-Cell Therapy in Patients with R/R DLBCL

QI Deng, Jia Wang, Rui Cui, Juan Mu, Xin Li, Qing Li, Lugui Qiu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3482.
https://doi.org/10.1182/blood-2023-182855
Published: 2023
Journal Articles

Fedratinib Treatment Reduces the Inflammatory Cytokine Profile and Decreases Exhausted T Cells Correlating with Clinical Response in Patients with Myelofibrosis: Biomarker Analysis from the Phase 3 FREEDOM2 Trial

Danny Jeyaraju, Sheida Hayati, Jia Wang, Claire N Harrison, Jean-Jacques Kiladjian, Christopher Hernandez, Patrick Brown, Daniel Lopes De Menezes, Anita K. Gandhi, Rajasekhar N.V.S. Suragani
Journal: Blood
Blood (2023) 142 (Supplement 1): 4526.
https://doi.org/10.1182/blood-2023-180419
Published: 2023
Journal Articles

Efficacy and Safety of Ino Combined with Reduce Dose R-GDP Regimen in Patients with Relapsed/Refractory B-Cell NHL in China

Xin Li, Rui Cui, Jia Wang, Juan Mu, Yili Jiang, Jingyi Li, Lugui Qiu, QI Deng
Journal: Blood
Blood (2023) 142 (Supplement 1): 6880.
https://doi.org/10.1182/blood-2023-182822
Published: 2023
Journal Articles

The non-cell-autonomous function of ID1 promotes AML progression via ANGPTL7 from the microenvironment

Ming-Yue Fei, Yong Wang, Bin-He Chang, Kai Xue, Fangyi Dong, Dan Huang, Xi-Ya Li, Zi-Juan Li, Cheng-Long Hu, Ping Liu, Ji-Chuan Wu, Peng-Cheng Yu, Ming-Hua Hong, Shu-Bei Chen, Chun-Hui Xu, Bing-Yi Chen, Yi-Lun Jiang, Na Liu, Chong Zhao, Jia-Cheng Jin, Dan Hou, Xin-Chi Chen, Yi-Yi Ren, Chu-Han Deng, Jia-Ying Zhang, Li-juan Zong, Rou-Jia Wang, Fei-Fei Gao, Hui Liu, Qun-Ling Zhang, Ling-Yun Wu, Jinsong Yan, Shuhong Shen, Chun-Kang Chang, Xiao-Jian Sun, Lan Wang
Journal: Blood
Blood (2023) 142 (10): 903–917.
https://doi.org/10.1182/blood.2022019537
Published: 2023
Includes: Supplemental data
Journal Articles

Safety and Efficacy of Fedratinib in Patients with Primary (P), Post-Polycythemia Vera (Post-PV), and Post-Essential Thrombocythemia (Post-ET) Myelofibrosis (MF) Previously Treated with Ruxolitinib: Primary Analysis of the FREEDOM Trial

Vikas Gupta, Abdulraheem Yacoub, Srdan Verstovsek, Ruben Mesa, Claire Harrison, Alessandro M. Vannucchi, Jean-Jacques Kiladjian, H. Joachim Deeg, Salman Fazal, Lynda Foltz, Ryan J. Mattison, Carole B. Miller, Vinod Parameswaran, Patricia Martin-Regueira, Christopher Hernandez, Jia Wang, Moshe Talpaz
Journal: Blood
Blood (2022) 140 (Supplement 1): 3935–3937.
https://doi.org/10.1182/blood-2022-156669
Published: 2022
Journal Articles

Preliminary Safety and Efficacy Results of EDI001: An Investigator Initiated Trial on CRISPR/Cas9-Modified Autologous CD34 + Hematopoietic Stem and Progenitor Cells for Patients with Transfusion Dependent β-Thalassemia

Jun Shi, Riguo Fang, Zhen Gao, Zhongyu Shi, Zhexiang Kuang, Yongjian Zhang, Lele Zhang, Huihui Yang, Yingchi Zhang, Dehui Zou, Liwei Fang, Jiali Sun, Qiang Li, Yao Zou, Hong Pan, Jingyu Zhao, Liyun Li, Xiao Yu, Jing Xu, Chun Xu, Yanjie Liu, Weiwei Wang, Jia Shi, Jie Liu, Jia Wang, Nian Shi, Lei Yang, Weiqiang Wang, Suyi Li, Moye Shi, Xiaoshuang Zhang, Pengfei Yuan, Wensheng Wei, Dong Wei, Tao Cheng
Journal: Blood
Blood (2022) 140 (Supplement 1): 10652–10653.
https://doi.org/10.1182/blood-2022-166365
Published: 2022
Journal Articles

CD19 CAR-T Cells Treatment Conferred a Sustained Remission in Patients with Chemotherapy-Refractory MRD in B-ALL

Wenyi Lu, MD, Yunxiong Wei, Yaqing Cao, Xia Xiao, MD, Qing Li, Hairong Lyu, Yili Jiang, Huan Zhang, Jia Wang, Xin Li, Yanyu Jiang, Meng Juanxia, Yuan Ting, Haibo Zhu, Xiaoyuan He, Xin Jin, Rui Sun, Tao Sui, Kaiqi Liu, Mingfeng Zhao, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 48.
https://doi.org/10.1182/blood-2020-140431
Published: 2020
Journal Articles

Humanized CD19 CAR-T Cell Combined with Multiple Combination Treatments in Relapsed/Refractory B-Cell Non-Hodgkin Lymphoma

Jia Wang, Ji-jun Yuan, Juan Mu, Qing Li, Nan Mou, Zhen-xing Yang, Wei Li, Lanfang Li, Peiqi Zhao, Xianhuo Wang, Yedi Pu, Huilai Zhang, MD, Qi Deng
Journal: Blood
Blood (2019) 134 (Supplement_1): 5346.
https://doi.org/10.1182/blood-2019-127896
Published: 2019
Journal Articles

Anti-CD19-CAR T-Cell from Patients Relapsed after Allo-HSCT with a Low Level of Donor Chimerism Restored to Complete Donor Chimerism: Successful Cases and Analysis

Qing Li, Juan Mu, Zhen-xing Yang, Nan Mou, Jia Wang, Ji-jun Yuan, Yanyu Jiang, Meng Juanxia, Qi Deng
Journal: Blood
Blood (2019) 134 (Supplement_1): 5628.
https://doi.org/10.1182/blood-2019-127850
Published: 2019
Journal Articles

Embryonic and hematopoietic stem cells express a novel SH2–containing inositol 5′-phosphatase isoform that partners with the Grb2 adapter protein

Zheng Tu, John M. Ninos, Zhengyu Ma, Jia-Wang Wang, Maria P. Lemos, Caroline Desponts, Tomar Ghansah, Julie M. Howson, William G. Kerr
Journal: Blood
Blood (2001) 98 (7): 2028–2038.
https://doi.org/10.1182/blood.V98.7.2028
Published: 2001